CAS 290297-26-6
:Netupitant
Descrizione:
Netupitant è un antagonista selettivo del recettore neurochinina-1 (NK1) utilizzato principalmente nella prevenzione di nausea e vomito associati alla chemioterapia. Spesso viene combinato con palonosetron, un antagonista del recettore 5-HT3, per aumentarne l'efficacia. La formula molecolare di Netupitant indica che contiene atomi di carbonio, idrogeno, azoto e ossigeno, riflettendo la sua natura organica. Questo composto è caratterizzato dalla sua alta affinità per il recettore NK1, che gioca un ruolo cruciale nella risposta emetica. Netupitant viene tipicamente somministrato per via orale ed è ben assorbito nel tratto gastrointestinale. La sua farmacocinetica mostra una emivita relativamente lunga, consentendo una somministrazione una volta al giorno. La sostanza è generalmente ben tollerata, con effetti collaterali comuni che includono affaticamento, stitichezza e mal di testa. Grazie al suo meccanismo d'azione, Netupitant è particolarmente efficace nella gestione della nausea e del vomito indotti dalla chemioterapia, rendendolo un'opzione terapeutica preziosa in contesti oncologici.
Formula:C30H32F6N4O
InChI:InChI=1S/C30H32F6N4O/c1-19-8-6-7-9-23(19)24-17-26(40-12-10-38(4)11-13-40)37-18-25(24)39(5)27(41)28(2,3)20-14-21(29(31,32)33)16-22(15-20)30(34,35)36/h6-9,14-18H,10-13H2,1-5H3
InChI key:InChIKey=WAXQNWCZJDTGBU-UHFFFAOYSA-N
SMILES:N(C(C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1)=O)(C)C=2C(=CC(=NC2)N3CCN(C)CC3)C4=C(C)C=CC=C4
Sinonimi:- 2-[3,5-Bis(trifluoromethyl)phenyl]-N-[6-(4-methylpiperazin-1-yl)-4-o-tolylpyridin-3-yl]-N-methylisobutyramide
- Benzeneacetamide, N,alpha,alpha-trimethyl-N-(4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl)-3,5-bis(trifluoromethyl)-
- Benzeneacetamide, N,α,α-trimethyl-N-[4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)-
- N,α,α-Trimethyl-N-[4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)benzeneacetamide
- Netupitan
- Netupitant
- Ro 67-31898/000
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
8 prodotti.
Benzeneacetamide, N,α,α-trimethyl-N-[4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)-
CAS:Formula:C30H32F6N4OPurezza:99%Colore e forma:SolidPeso molecolare:578.59172-(3,5-Bis(Trifluoromethyl)Phenyl)-N,2-Dimethyl-N-(6-(4-Methylpiperazin-1-Yl)-4-(O-Tolyl)Pyridin-3-Yl)Propanamide
CAS:2-(3,5-Bis(Trifluoromethyl)Phenyl)-N,2-Dimethyl-N-(6-(4-Methylpiperazin-1-Yl)-4-(O-Tolyl)Pyridin-3-Yl)PropanamidePurezza:99%Peso molecolare:578.59g/molNetupitant
CAS:Netupitant (CID 6451149) is a specific neurokinin 1 (NK1) receptor antagonist (Ki: 0.95 nM).Formula:C30H32F6N4OPurezza:99.43%Colore e forma:SolidPeso molecolare:578.59Netupitant
CAS:Prodotto controllato<p>Applications Netupitant is a potent and selective neurokinin-1 receptor (NK1) receptor antagonist. It is achiral and orally active.<br>References Hoffmann, T., et al.: Bioorg. Med. Chem. Lett., 16, 1362 (2006); Di Fabio, R., et al.: Bioorg. Med. Chem., 21, 6264 (2013)<br></p>Formula:C30H32F6N4OColore e forma:NeatPeso molecolare:578.59Netupitant
CAS:<p>Netupitant is an antiemetic drug that is used to treat bowel disease. It has been shown in a two-way crossover study to have biological properties in the treatment of disease activity. Netupitant inhibits the neurokinin-1 receptor and matrix effect, which are responsible for the development of cancerous cells. The drug also has inhibitory properties on p-gp substrates and netupitant, which prevents it from being absorbed by the gastrointestinal tract. This allows netupitant to be transported through the blood-brain barrier into malignant brain tumours, where it can act as a cytotoxic agent.</p>Purezza:Min. 95%






